Skip to main content
. 2012 Sep 4;7(9):e40267. doi: 10.1371/journal.pone.0040267

Figure 13. MAPK signaling pathway in IL-5-, IL-20-, and IL-28A-treated bladder cancer cells.

Figure 13

(A, B) Cells were incubated in IL-5, IL-20, and IL-28A (100 ng/ml) for the indicated times, and were then harvested, lysed and subjected to immunoblot analysis for the activation levels of MAPK using specific antibodies.